SUBSCRIBE TO OUR FREE NEWSLETTER

SUBSCRIBE TO OUR FREE NEWSLETTER

Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

* indicates required
5
#000000
#FFFFFF
The Progressive

NewsWire

A project of Common Dreams

For Immediate Release
Contact: Phone: (202) 588-1000

After Caving on 'Orphan Drug' Designation, Gilead Must Commit to Licensing and Mass Production

Statement of Peter Maybarduk, Director, Public Citizen’s Access to Medicines Program

WASHINGTON

Shortly after Public Citizen and 50 groups demanded that Gilead Sciences relinquish its government-sanctioned monopoly guarantee for a potential COVID-19 treatment, the pharmaceutical giant agreed to do so.

It was outrageous that Gilead ever sought an "orphan drug" designation for remdesivir, which aims to treat a patient population that easily may number in the tens of millions in the U.S. alone. That designation would confer a special seven-year monopoly on the drug. Thankfully, under pressure, the company has backed down. There's no doubt that the prospect of an enormous public backlash is what made the difference.

But today's action is not enough. If remdesivir proves to be a viable treatment for COVID-19, then the world cannot afford to have one manufacturer maintain a monopoly over it, particularly given the huge amount of public investment that has gone into the drug. Gilead must do more than make vague promises of reasonable pricing. It should commit right now to license the right and needed know-how to manufacture remdesivir to all qualified producers, in exchange for a modest royalty.

If the drug proves viable as a COVID-19 treatment, the U.S. and the world will need the product available at a low price that reflects both the public health need and the potentially enormous market - with production at an unprecedented scale.

Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people - not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

(202) 588-1000